Miguel Rivera

2.2k total citations
90 papers, 1.7k citations indexed

About

Miguel Rivera is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Miguel Rivera has authored 90 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Cardiology and Cardiovascular Medicine, 26 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in Miguel Rivera's work include Cardiovascular Function and Risk Factors (34 papers), Heart Failure Treatment and Management (24 papers) and Cardiomyopathy and Myosin Studies (12 papers). Miguel Rivera is often cited by papers focused on Cardiovascular Function and Risk Factors (34 papers), Heart Failure Treatment and Management (24 papers) and Cardiomyopathy and Myosin Studies (12 papers). Miguel Rivera collaborates with scholars based in Spain, United Kingdom and United States. Miguel Rivera's co-authors include Manuel Portolés, Esther Roselló‐Lletí, José Ramón González‐Juanatey, Francisca Lago, Luis Martínez‐Dolz, Estefanía Tarazón, Raquel Cortés, Antonio Salvador, Vicente Bertoméu and Ana Ortega and has published in prestigious journals such as PLoS ONE, The Journal of Physiology and Scientific Reports.

In The Last Decade

Miguel Rivera

90 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miguel Rivera Spain 25 798 580 266 213 174 90 1.7k
Leonardo Schirone Italy 14 509 0.6× 584 1.0× 292 1.1× 158 0.7× 151 0.9× 37 1.3k
Peili Bu China 26 375 0.5× 787 1.4× 273 1.0× 137 0.6× 383 2.2× 64 1.7k
Srikanth Givvimani United States 25 367 0.5× 719 1.2× 184 0.7× 173 0.8× 373 2.1× 50 1.8k
Willard W. Sharp United States 21 464 0.6× 1.0k 1.8× 225 0.8× 153 0.7× 198 1.1× 40 1.9k
Michael F. Allard Canada 30 1.2k 1.5× 1.1k 1.8× 304 1.1× 469 2.2× 418 2.4× 60 2.3k
Xianzhong Meng United States 27 623 0.8× 721 1.2× 239 0.9× 339 1.6× 260 1.5× 45 2.4k
Brian S. Cain United States 23 655 0.8× 555 1.0× 235 0.9× 307 1.4× 172 1.0× 38 1.9k
Yi Pan Canada 18 457 0.6× 591 1.0× 464 1.7× 242 1.1× 392 2.3× 41 1.7k
María Paz Ocaranza Chile 24 1.0k 1.3× 672 1.2× 81 0.3× 185 0.9× 168 1.0× 78 2.0k

Countries citing papers authored by Miguel Rivera

Since Specialization
Citations

This map shows the geographic impact of Miguel Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Rivera more than expected).

Fields of papers citing papers by Miguel Rivera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Rivera. The network helps show where Miguel Rivera may publish in the future.

Co-authorship network of co-authors of Miguel Rivera

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Rivera. A scholar is included among the top collaborators of Miguel Rivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Rivera. Miguel Rivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vicent, Lourdes, Jesús Álvarez‐García, Rafael Vázquez, et al.. (2023). Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction. Journal of Clinical Medicine. 12(8). 3028–3028. 4 indexed citations
2.
Martínez‐Dolz, Luis, José Ramón González‐Juanatey, Francisca Lago, et al.. (2019). The altered expression of autophagy-related genes participates in heart failure: NRBP2 and CALCOCO2 are associated with left ventricular dysfunction parameters in human dilated cardiomyopathy. PLoS ONE. 14(4). e0215818–e0215818. 14 indexed citations
3.
Ortega, Ana, Estefanía Tarazón, Luis Martínez‐Dolz, et al.. (2018). Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis. PLoS ONE. 13(1). e0190987–e0190987. 14 indexed citations
4.
Mouriño-Álvarez, Laura, Félix Gil-Dones, Fernando de la Cuesta, et al.. (2017). A clinical perspective on the utility of alpha 1 antichymotrypsin for the early diagnosis of calcific aortic stenosis. Clinical Proteomics. 14(1). 12–12. 15 indexed citations
5.
Roselló‐Lletí, Esther, Estefanía Tarazón, Ana Ortega, et al.. (2017). Thyroid hormone biosynthesis machinery is altered in the ischemic myocardium: An epigenomic study. International Journal of Cardiology. 243. 27–33. 12 indexed citations
6.
Ortega, Ana, Esther Roselló‐Lletí, Estefanía Tarazón, et al.. (2016). TRPM7 is Down-Regulated in Both Left Atria and Left Ventricle of Ischaemic Cardiomyopathy Patients and Highly Related to Changes in Ventricular Function. ESC Heart Failure. 3(3). 220–224. 11 indexed citations
7.
Roselló‐Lletí, Esther, Ana Ortega, Estefanía Tarazón, et al.. (2016). New Altered Non-Fibrillar Collagens in Human Dilated Cardiomyopathy: Role in the Remodeling Process. PLoS ONE. 11(12). e0168130–e0168130. 28 indexed citations
8.
Roselló‐Lletí, Esther, Estefanía Tarazón, Ana Ortega, et al.. (2016). Protein Inhibitor of NOS1 Plays a Central Role in the Regulation of NOS1 Activity in Human Dilated Hearts. Scientific Reports. 6(1). 30902–30902. 6 indexed citations
9.
García‐Rúa, Vanessa, Sandra Feijóo‐Bandín, Maria García-Vence, et al.. (2016). Metabolic alterations derived from absence of Two-Pore Channel 1 at cardiac level. Journal of Biosciences. 41(4). 643–658. 6 indexed citations
10.
Álvarez‐García, Jesús, Andreu Ferrero‐Gregori, Teresa Puig, et al.. (2015). A Simple Validated Method for Predicting the Risk of Hospitalization for Worsening of Heart Failure in Ambulatory Patients: The Redin-SCORE. European Journal of Heart Failure. 17(8). 818–827. 43 indexed citations
11.
Mouriño-Álvarez, Laura, Sergio Alonso‐Orgaz, Esther Roselló‐Lletí, et al.. (2015). iTRAQ proteomic analysis of extracellular matrix remodeling in aortic valve disease. Scientific Reports. 5(1). 17290–17290. 34 indexed citations
12.
Herrer, Isabel, Esther Roselló‐Lletí, Ana Ortega, et al.. (2015). Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy. BMC Medical Genomics. 8(1). 14–14. 18 indexed citations
13.
Molina‐Navarro, Maria Micaela, Esther Roselló‐Lletí, Estefanía Tarazón, et al.. (2013). Heart failure entails significant changes in human nucleocytoplasmic transport gene expression. International Journal of Cardiology. 168(3). 2837–2843. 21 indexed citations
14.
Morillas, Pedro, Juan Quiles, Jesús Castillo, et al.. (2013). Circulating biomarkers of collagen metabolism in arterial hypertension. Journal of Hypertension. 31(8). 1611–1617. 20 indexed citations
15.
Cortés, Raquel, Miguel Rivera, Esther Roselló‐Lletí, et al.. (2012). Differences in MEF2 and NFAT Transcriptional Pathways According to Human Heart Failure Aetiology. PLoS ONE. 7(2). e30915–e30915. 23 indexed citations
16.
Cortés, Raquel, Esther Roselló‐Lletí, Miguel Rivera, et al.. (2011). Expression of B-type natriuretic peptide forms in ischemic human hearts. International Journal of Cardiology. 158(2). 199–204. 5 indexed citations
17.
Roselló‐Lletí, Esther, Miguel Rivera, Vicente Miró, et al.. (2009). Valor pronóstico de big endotelina-1 en pacientes con insuficiencia cardíaca y clase funcional moderadamente sintomática. Medicina Clínica. 133(5). 173–176. 1 indexed citations
18.
Cortés, Raquel, Manuel Portolés, Antonio Salvador, et al.. (2006). Diagnostic and Prognostic Value of Urine NT-proBNP Levels in Heart Failure Patients. European Journal of Heart Failure. 8(6). 621–627. 46 indexed citations
19.
Rivera, Miguel, Raquel Cortés, Antonio Salvador, et al.. (2005). Obese Subjects with Heart Failure Have Lower N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Irrespective of Aetiology. European Journal of Heart Failure. 7(7). 1168–1170. 42 indexed citations
20.
Rivera, Miguel, Raquel Taléns‐Visconti, Rafael Sirera, et al.. (2004). Soluble TNF-α and Interleukin-6 Receptors in the Urine of Heart Failure Patients. Their Clinical Value and Relationship with Plasma Levels. European Journal of Heart Failure. 6(7). 877–882. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leonardo Schirone Breakdown of academic impact, for papers by Peili Bu Breakdown of academic impact, for papers by Srikanth Givvimani Breakdown of academic impact, for papers by Willard W. Sharp Breakdown of academic impact, for papers by Michael F. Allard Breakdown of academic impact, for papers by Xianzhong Meng Breakdown of academic impact, for papers by Brian S. Cain Breakdown of academic impact, for papers by Yi Pan Breakdown of academic impact, for papers by María Paz Ocaranza
Rankless by CCL
2026